MET and neoplasm: In order to identify a putative bypass mechanism that is required for tumor survival after c-Met inhibition, we used c-Met shRNA to develop a stable c-Met knockdown (KD) cell line in the c-Met+ MHCC97-H cell line (referred to as MHCC97-H c-Met KD cells).